Akèy › Neurofibrosarkòm › Massachusetts › Boston
Etid klinik pou Neurofibrosarkòm nan Boston, MA
4 etid pou Neurofibrosarkòm ap chèche patisipan nan sit nan ak bò kote Boston (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors
Ap rekriteFaz 1/2
- Massachusetts General Hospital, Boston
- Dana Farber Cancer Institute, Boston
SPEARHEAD-3 Pediatric Study
Ap rekriteFaz 1/2
- Dana Farber Cancer Institute, Boston
NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)
Ap rekriteFaz 1/2
- Dana Farber Cancer Institute, Boston
A Study of Selinexor in People With Wilms Tumors and Other Solid Tumors
Ap rekriteFaz 2
- Dana Farber Cancer Institute (Data Collection Only), Boston
Etid Neurofibrosarkòm nan lòt vil
- Washington, DC6 etid
- New York City, NY6 etid
- St. Louis, MO4 etid
- Chicago, IL3 etid
- Mountain View, CA3 etid
- Edison, NJ3 etid
- Cincinnati, OH3 etid
- Queens, NY3 etid
- Houston, TX3 etid
Lòt etid nan Boston
- Kansè nan tete111 etid
- Kansè Poumon ki pa ti selil90 etid
- Kansè (tout kalite)86 etid
- Kansè kolorektal63 etid
- Kansè Metastatik63 etid
- Kansè poumon62 etid
- Kansè ovè61 etid
- Kansè pwostat59 etid
- Depresyon52 etid
- Kansè Endomèt50 etid
- Ensifizyans kadyak44 etid
- Leksemi mieloïd egi44 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.